8-K: AMN Healthcare Q1 2026 Results Exceed Expectations

AMN Healthcare reported strong first quarter 2026 financial results, with revenue and adjusted EBITDA surpassing guidance due to robust performance in key staffing segments.

Summary

• AMN Healthcare announced first quarter 2026 results, reporting revenue of $1.378 billion and adjusted EBITDA of $166 million.
• GAAP diluted earnings per share (EPS) was $1.59, while adjusted diluted EPS was $2.10, a significant increase from the prior year.
• The company exceeded its guidance for revenue and earnings, driven by strong performance in travel nurse, allied, and international nurse staffing.
• Travel nursing volume and revenue saw year-over-year growth for the first time since 2022.
• Cash flow from operations was $562 million, and the company ended the quarter with a cash balance of $561 million.
• The leverage ratio was 1.6x, with $750 million in debt and an undrawn revolving credit facility.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, with results significantly exceeding expectations and key growth metrics returning to positive territory.

Positives

• First quarter revenue and earnings exceeded guidance.
• Travel nursing volume and revenue grew year-over-year for the first time since 2022.
• Allied, schools, international nurse, and search businesses all delivered year-over-year revenue growth.
• Strong cash flow from operations of $562 million.
• Quarter-end cash balance of $561 million.
• Leverage ratio improved to 1.6x.
• Adjusted diluted EPS increased by 366% year-over-year to $2.10.
• Adjusted EBITDA increased by 159% year-over-year to $166 million.

Negatives

• Physician and Leadership Solutions segment revenue decreased 6% year-over-year.
• Technology and Workforce Solutions segment revenue decreased 15% year-over-year.
• Consolidated gross margin was 190 basis points lower year-over-year at 26.8%.
• Labor disruption events contributed significantly to revenue, raising questions about sustainability.
• Second quarter 2026 revenue is expected to be lower than the prior year.

Risks

• The duration and extent to which healthcare entities adjust their utilization of temporary professionals.
• The magnitude and duration of the effects of the post-COVID-19 pandemic environment on demand and supply trends.
• The ability to recruit and retain sufficient quality healthcare professionals at reasonable costs.
• The effects of economic downturns, inflation, or slow recoveries on demand for services.
• Potential security breaches and cybersecurity incidents.
• The financial condition and cash flow of hospitals and healthcare systems impacting their ability to make payments.

Future Outlook

For the second quarter of 2026, consolidated revenue is expected to be 4-6% lower than the prior year. Nurse and Allied Solutions segment revenue is projected to be down 0-2% year-over-year, Physician and Leadership Solutions segment revenue down 6-8% year-over-year, and Technology and Workforce Solutions segment revenue down 14-16% year-over-year.

Management Comments

• Our first quarter performance demonstrated strong execution across AMN, with results exceeding our expectations and guidance while navigating a dynamic market environment.
• We delivered solid underlying growth in Nurse and Allied Solutions, saw momentum return in international staffing and search, and continued to advance our technology-enabled workforce solutions.
• The AMN team did an outstanding job supporting our clients and healthcare professionals, demonstrating the power of our enhanced technology platform and solutions to deliver at our highest level since the pandemic.

Industry Context

StockSavvy.ai notes that AMN Healthcare's strong Q1 2026 results, particularly the return to year-over-year growth in travel nursing, indicate a potential stabilization or recovery in the healthcare staffing market, which has been volatile post-pandemic. The company's performance outperforming guidance suggests effective navigation of current market dynamics.

Comparison to Industry Standards

• AMN Healthcare's adjusted EBITDA margin of 12.1% for Q1 2026 is a significant improvement from 7.3% in Q1 2025, indicating enhanced operational efficiency or favorable market conditions compared to the previous year.
• The year-over-year revenue growth in travel nursing, a key segment for many staffing firms, is a positive indicator for the broader industry, which has faced headwinds.
• The company's leverage ratio of 1.6x is within a healthy range for the industry, suggesting prudent financial management.

Stakeholder Impact

• Shareholders: Positive impact from exceeding earnings expectations and improved financial metrics.
• Employees: Potential for increased bonuses or incentives due to strong performance.
• Clients: Continued access to critical healthcare professionals, especially nurses and allied health staff.
• Healthcare Professionals: Opportunities for assignments, particularly in travel nursing, with renewed growth.

Next Steps

• Host conference call to discuss Q1 2026 financial results and Q2 2026 outlook on May 7, 2026.
• Continue to advance technology-enabled workforce solutions.
• Support clients and healthcare professionals with enhanced technology platform and solutions.

Key Dates

Recommendation

The company has demonstrated strong execution, exceeding guidance with significant year-over-year growth in key metrics like adjusted EPS and EBITDA. The return of growth in travel nursing and robust cash flow position the company favorably, despite a cautious near-term outlook. The strong performance suggests effective management and a resilient business model in the healthcare staffing sector.

Keywords

AMN Healthcare, Q1 2026 Results, Healthcare Staffing, Travel Nursing, Allied Health, Financial Report, Earnings, Adjusted EBITDA